EUHASS: The European haemophilia safety surveillance system

Thrombosis Research

Volumn 127, Issue SUPPL. 2, 2011, Pages

  Makris, M ^a   Calizzani, G ^b   Fischer, K ^c   Gilman, E A ^a   Hay, C R M ^d   Lassila, R ^e   Lambert, T ^f   Ludlam, C A ^g   Mannucci, P M ^h  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b European Haemophilia Consortium ^*  (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g European Association for Haemophilia and Allied Disorders   (United Kingdom)

^h UNIVERSITY OF MILAN   (Italy)

Author keywords

Adverse events; Haemophilia; Inhibitor; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR;

ANAMNESIS; ARTICLE; BLOOD CLOTTING DISORDER; DATA BASE; DRUG SURVEILLANCE PROGRAM; FUNDING; HEALTH CARE ORGANIZATION; HEMOPHILIA; INFORMATION TECHNOLOGY; MEDICAL ETHICS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; BLOOD COAGULATION DISORDERS, INHERITED; BLOOD COAGULATION FACTORS; DATABASES, FACTUAL; EUROPE; HEMOPHILIA A; HUMANS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS;

EID: 78650784094     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(10)70150-X     Document Type: Article

References (6)

1. G Theodossiades, M Makris Transfusion transmitted infections: epidemiology, risks and prevention Haema 4 2001 24 38
2. R Lassila, E Armstrong Current challenges in pharmacovigilance in bleeding disorders: converting burden to benefit Haemophilia 16 2010 231 237
3. M Weinstein, M Makris, CA Ludlam Biovigilance and pharmacovigilance for haemophilia Haemophilia 16 Suppl 5 2010 17 21
4. PM Mannucci, S Duga, F Peyvandi Recessively inherited coagulation disorders Blood 104 2004 1243 1252
5. G White, F Rosendaal, LM Aledort, JM Lusher, C Rothchild, J Ingerslev Definitions of haemophilia Thromb Haemost 85 2001 560
6. CM Millar, N Connor, G Dolan, CA Lee, M Makris, J Wilde Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders Haemophilia 16 2010 305 315